Discovery of new genes implicated in hereditary diseases or cancer progression is challenging and advancing rapidly with an increase in the amount of cohort data to analyze from next generation sequencing (NGS) data to associations between gene variants and diseases, and finally to biological mechanisms of these gene variants. Combining QIAGEN CLC Genomics Workbench, QCII-T, and IPA, scientists can analyze sequencing data obtained from a variety of NGS technologies, annotate gene variants using the world’s most comprehensive and up-to-date curated scientific evidence, and find biological connections in gene variants with manually curated scientific findings. Get valuable and reliable insights for your research project and speed up your discoveries by using a streamlined NGS analysis workflow.

In this webinar, attendees will have the opportunity to:

1. Learn how to import whole genome or exome sequencing data into QIAGEN CLC Genomics Workbench and use the ultra-fast LightSpeed Module that delivers end-to-end NGS FASTQ to VCF pipeline;

2. Explore capabilities in QCII-T which can enable scientists to accelerate discoveries from hereditary or tumor cohort analyses to find associations between gene variants and diseases;

3. Learn how to use IPA and its manually curated content among other integrated scientific evidence to uncover novel biological mechanisms underlying these gene variants.